Ishita Drugs and Industries Limited (BOM:524400)
72.79
+0.03 (0.04%)
At close: Nov 16, 2026
BOM:524400 Revenue
Ishita Drugs and Industries had revenue of 31.92M INR in the quarter ending September 30, 2026, with 4.02% growth. This brings the company's total for the last twelve months to 124.07M, down -27.72% year-over-year. In the fiscal year ending March 31, 2026, Ishita Drugs and Industries had annual revenue of 146.60M, down -2.25%. That makes Ishita Drugs and Industries the 43,189th largest company in the world by revenue and 4,491st in India.
Revenue (ttm)
124.07M
Revenue Growth
-27.72%
P/S Ratio
1.75
Revenue / Employee
7.30M
Employees
17
Market Cap
217.66M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 146.60M | -3.37M | -2.25% |
| Mar 31, 2025 | 149.97M | -1.90M | -1.25% |
| Mar 31, 2024 | 151.88M | 31.15M | 25.81% |
| Mar 31, 2023 | 120.72M | -20.18M | -14.32% |
| Mar 31, 2022 | 140.90M | 1.41M | 1.01% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Supha Pharmachem | 5.27B |
| Panchsheel Organics | 1.10B |
| Tyche Industries | 503.78M |
| Auro Laboratories | 407.90M |
| Crestchem | 338.33M |
| Vasundhara Rasayans | 295.25M |
| Link Pharma Chem | 274.60M |
| Krebs Biochemicals & Industries | 268.57M |